Comparison of treatment practices for nontuberculous mycobacterial pulmonary disease in Japan, Europe, and United States

J. van Ingen, J. Adjemian, K. Morimoto, D. Wagner, C. Lange, C. Haworth, J. Gallagher, D. R. Prevots, R. Gupta, D. Griffith (Nijmegen, Netherlands; Bethesda, Spartanburg, Monmouth Junction, Tyler, United States Of America; Tokyo, Japan; Freiburg, Borstel, Germany; Cambridge, United Kingdom)

Source: International Congress 2014 – The epidemiology of respiratory infections and lung cancer
Session: The epidemiology of respiratory infections and lung cancer
Session type: Thematic Poster Session
Number: 1066
Disease area: Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. van Ingen, J. Adjemian, K. Morimoto, D. Wagner, C. Lange, C. Haworth, J. Gallagher, D. R. Prevots, R. Gupta, D. Griffith (Nijmegen, Netherlands; Bethesda, Spartanburg, Monmouth Junction, Tyler, United States Of America; Tokyo, Japan; Freiburg, Borstel, Germany; Cambridge, United Kingdom). Comparison of treatment practices for nontuberculous mycobacterial pulmonary disease in Japan, Europe, and United States. Eur Respir J 2014; 44: Suppl. 58, 1066

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Annual prevalence and treatment estimates of nontuberculous mycobacterial pulmonary disease in Europe: A NTM-NET collaborative study
Source: International Congress 2014 – The epidemiology of respiratory infections and lung cancer
Year: 2014


Epidemiology and clinical features of nontuberculous mycobacterial lung disease in a subtropical region in Japan: Analysis with a 7-year data in two major hospitals
Source: International Congress 2016 – Clinical and microbiological aspects of bronchiectasis and non-tuberculous mycobacterium (NTM) infections
Year: 2016


Non-tuberculous mycobacterium incidence & treatment rates in university hospitals of North Midlands (UK)
Source: International Congress 2015 – Non-tuberculous mycobacteria and molecular microbiology
Year: 2015


Tuberculosis (TB) screening in immigrants in a large city in the United Kingdom (UK)
Source: Annual Congress 2006 - Epidemiology and control of tuberculosis
Year: 2006


The cost of medical management of pulmonary nontuberculous mycobacterial disease in Ontario, Canada
Source: Eur Respir J 2011; 37: 1158-1165
Year: 2011



Rifampicin-resistant tuberculosis (RR-TB) in eastern Europe
Source: International Congress 2016 – Rifampicin resistance, MDRTB, and new drug treatments
Year: 2016


Molecular identification of nontuberculous mycobacteria isolated from patients in northeast Iran
Source: International Congress 2016 – Epidemiological aspects of tuberculosis and other respiratory conditions: from lung cancer to late-onset Pompe's disease
Year: 2016


Differences in tuberculosis disease among immigrant and native populations
Source: Annual Congress 2013 –Tuberculosis: clinical epidemiology and public health
Year: 2013


The costs of MDR/XDR tuberculosis in Barcelona (Spain): Cases treated with DOTs/DOT plus in a specialized centre
Source: International Congress 2016 – Treatment management options and costs: vitamin D, Matrix metalloproteinases (MMPs), nutrition, and human genetics
Year: 2016

Nontuberculous mycobacteria in the Danish population, incidence rate and clinical importance during 24 years
Source: International Congress 2015 – Bronchiectasis and NTM infections: clinical aspects and research outlook
Year: 2015

Effect of LAEDI (Local awareness and early diagnosis initiatives) in a low socioeconomic area population in United Kingdom
Source: International Congress 2014 – Epidemiology, pathogenesis and quality management of thoracic tumours
Year: 2014

TB and MDR/XDR-TB in European Union and European Economic Area countries: managed or mismanaged?
Source: Eur Respir J 2012; 39: 619-625
Year: 2012



Asthma ICs prescriptions in primary care in France and the United Kingdom: Are they similar?
Source: International Congress 2016 – Asthma management in primary care
Year: 2016


Active detection of tuberculosis in homeless populations may reduce the incidence of tuberculosis in the general population
Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 2
Year: 2014


Geographic origin and other determinants of site of tuberculosis disease in European countries
Source: International Congress 2014 – Tuberculosis epidemiology: novel features
Year: 2014

Screening immigrants to Ireland from countries with a high prevalence of tuberculosis would be clinically beneficial and cost effective
Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection in subpopulations
Year: 2013


Tuberculosis and HIV co-infection in European Union and European Economic Area countries
Source: Eur Respir J 2011; 38: 1382-1392
Year: 2011



Nontuberculous mycobacterial disease of the lungs in North-West region of Russia
Source: International Congress 2014 – Resistance, bacteriological profile and comorbidities in respiratory infections
Year: 2014

Comparison of tuberculosis surveillance systems in low-incidence industrialised countries
Source: Eur Respir J 2008; 32: 1616-1624
Year: 2008



Prevalence of nontuberculous mycobacteria in hospital watersof major cities of Khuzestan province, Iran
Source: International Congress 2016 – Epidemiological aspects of tuberculosis and other respiratory conditions: from lung cancer to late-onset Pompe's disease
Year: 2016